Entero Healthcare Solutions

1,315.65
+15.00
(1.15%)
Market Cap
5,657.00 Cr
EPS
10.81
PE Ratio
62.92
Dividend Yield
0.00 %
Industry
Retail
52 Week High
1,584.25
52 Week low
970.00
PB Ratio
3.37
Debt to Equity
0.35
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy100.00 %
100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
722.80 8,897.90 67.22 5,664.90 23.05 66 235.04 41.39
1,315.65 5,657.00 62.92 3,936.70 19.09 40 321.43 46.66
Growth Rate
Revenue Growth
19.09 %
Net Income Growth
-458.56 %
Cash Flow Change
19.22 %
ROE
-230.11 %
ROCE
-12.10 %
EBITDA Margin (Avg.)
52.86 %

Quarterly Financial Results

Quarterly Financials
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
832
888
901
998
994
1,043
1,111
1,312
1,367
Expenses
810
867
873
968
964
1,005
1,067
1,258
1,309
EBITDA
21
21
27
31
30
38
44
54
58
Operating Profit %
2 %
2 %
3 %
3 %
3 %
3 %
3 %
3 %
4 %
Depreciation
5
7
6
6
6
7
7
8
8
Interest
13
13
14
18
16
17
10
12
10
Profit Before Tax
3
1
7
7
8
14
27
35
39
Tax
-1
5
0
2
1
-8
7
9
10
Net Profit
4
-4
6
5
7
21
21
26
30
EPS in ₹
8.67
1.49
15.18
3.24
4.21
5.73
4.62
5.43
5.85

Balance Sheet

Balance Sheet
2021
2022
2023
2024
Total Assets
834
1,126
1,309
2,345
Fixed Assets
189
262
268
289
Current Assets
633
851
1,023
2,011
Capital Work in Progress
2
1
0
0
Investments
0
0
0
0
Other Assets
643
863
1,041
2,056
Total Liabilities
834
1,126
1,309
2,345
Current Liabilities
289
462
624
602
Non Current Liabilities
58
101
87
102
Total Equity
487
563
598
1,641
Reserve & Surplus
-32
-62
-73
1,593
Share Capital
0
4
4
44

Cash Flow

Cash Flow
2021
2022
2023
2024
Net Cash Flow
-11
14
-21
122
Investing Activities
-31
-162
-49
-704
Operating Activities
-69
-35
-45
-37
Financing Activities
89
211
73
863

Share Holding

% Holding
Sept 2023
Feb 2024
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
78.85 %
52.44 %
52.44 %
52.44 %
52.44 %
52.44 %
FIIs
0.00 %
0.00 %
23.30 %
23.32 %
23.82 %
22.21 %
DIIs
0.00 %
1.36 %
2.28 %
2.06 %
7.73 %
8.77 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
5.72 %
4.95 %
5.00 %
4.06 %
4.36 %
Others
21.15 %
40.48 %
17.03 %
17.18 %
11.95 %
12.23 %
No of Share Holders
51
58
80,864
66,400
36,767
33,172

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
2 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
1 day ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
2 days ago
Intimation Of Cancellation Of Analyst/ Institutional Investor Meeting Scheduled On February 21 2025
3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
8 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication
8 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation
9 days ago
Statement Of Deviation For The Quarter Ended December 31 2024
9 days ago
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
9 days ago
Integrated Filing (Financial)
9 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On February 12 2025
9 days ago
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024
9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 08, 2025, 19:52
Board Meeting Intimation for Approval And Take On Record The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31 2024.
Feb 03, 2025, 19:11
Intimation Regarding Receipt Of Listing And Trading Approval For 13940 Equity Shares From The BSE Limited (BSE) And National Stock Exchange Of India Limited (NSE)
Jan 31, 2025, 20:25
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
Jan 25, 2025, 11:30
Disclosure under Regulation 30A of LODR
Jan 16, 2025, 12:20
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Jan 16, 2025, 12:09
Appointment of Company Secretary and Compliance Officer
Jan 16, 2025, 12:04
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 13, 2025, 17:44
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
Jan 10, 2025, 17:45
Change Of Name Of Registrar And Share Transfer Agent ("RTA") Of The Company
Jan 02, 2025, 19:58
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 02, 2025, 19:54
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 02, 2025, 19:47
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 02, 2025, 19:43
Closure of Trading Window
Dec 23, 2024, 16:50

Technical Indicators

RSI(14)
Neutral
44.68
ATR(14)
Less Volatile
68.11
STOCH(9,6)
Neutral
25.26
STOCH RSI(14)
Neutral
22.18
MACD(12,26)
Bearish
-9.29
ADX(14)
Weak Trend
17.60
UO(9)
Bearish
49.67
ROC(12)
Downtrend And Accelerating
-16.06
WillR(14)
Neutral
-71.94